Avdl stock alert: halper sadeh llc is investigating whether the sale of avadel pharmaceuticals plc is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of avadel pharmaceuticals plc (nasdaq: avdl) to alkermes plc is fair to avadel shareholders. under the terms of the proposed transaction, avadel shareholders will receive $18.50 per share, plus a non-transferable contingent value right entitling holders to a potential additional cash payment of $1.50 per share, contingent upon final fda approval of lumryz™ for the treatment of idiopathic.
AVDL Ratings Summary
AVDL Quant Ranking